Bardet-Biedl Syndrome 13

Watchlist

(log in to enable)

Retrieved

2019-09-22

Source

Omim

Trials

—

Genes

MKS1, BBS10, SDCCAG8, LZTFL1, BBIP1, CEP290, ARL6, IFT27, BBS2, MKKS, BBS4, BBS1, TTC8, ALMS1, IFT172, C8orf37, NPHP1, TMEM67, TBC1D32, BBS7, TRIM32, BBS9, BBS5, BBS12, TRAPPC3, ASTN2, PIGX, CEP19, ZDHHC24, CCDC28B, LEP, GLIS2, RTEL1, PLLP, PYY3, SULT1A4, PEG13, AZIN1, STOML3, RIN2, MAGEL2, CBLL2, MARVELD2, MYO3B, INPP5E, USP35, MUL1, WDPCP, IFT74, CEP131, SCAPER, INVS, NPY2R, NPY, NMB, NDN, MYO9A, MYO7A, RAB8A, KIFC3, KIF2A, INSR, IL18, GPT, GFAP, ERG, CCT, TNFRSF11B, PRKN, PCM1, ADIPOQ, CEP164, STUB1, FEM1B, RAPGEF5, IQCB1, FEZ1, TRPV1, PDE6B, VEGFA, SULT1A3, RHO, RFX1, RCVRN, PECAM1, SLX1A-SULT1A3

Drugs

Adeno-associated virus serotype 8 containing the human RdCVF sequence and the human RdCVFL sequence, Combination of three adeno-associated viral vectors of serotype 8 containing the 5'-, the body- and the 3'- coding sequences of human CEP290 fused to inteins, Leuprolide acetate ( LUPRON INJECTION )

Interested in hearing about new therapies?

A number sign (#) is used with this entry because of evidence that Bardet-Biedl syndrome-13 (BBS13) is caused by compound heterozygous mutation in the MKS1 gene (609883) on chromosome 17q22.

Description

BBS13 is an autosomal recessive ciliopathy with features of obesity, polydactyly, and retinitis pigmentosa (Leitch et al., 2008; Xing et al., 2014).

For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900).

Clinical Features

Xing et al. (2014) reported a Chinese boy with BBS13. Although clinical details were not provided, the child was noted to have typical symptoms, such as retinitis pigmentosa, obesity, and polydactyly. Ophthalmologic examination showed bone-spicule hyperpigmentation and attenuated arteries.

Molecular Genetics

In a 2-year-old patient of Turkish descent with Bardet-Biedl syndrome, Leitch et al. (2008) identified compound heterozygosity for mutations in the MKS1 gene: a missense mutation (C492W; 609883.0006) and a 3-bp in-frame deletion resulting in deletion of phenylalanine (F371del; 609883.0007). Functional studies in zebrafish demonstrated that the missense mutation results in a hypomorphic allele and the deletion in a functionally null allele. The authors also detected heterozygous mutations in MKS1 in 5 families; 2 of these families also carried mutations in BBS10 (610148), 1 in heterozygosity and 1 in homozygosity, and a third family carried a homozygous mutation in BBS1 (209901). Leitch et al. (2008) concluded that their data extended the genetic stratification of ciliopathies and suggested that BBS and Meckel syndrome (see 609883), although distinct clinically, are allelic forms of the same molecular spectrum.

In a Chinese boy with BBS13, Xing et al. (2014) identified compound heterozygous missense mutations in the MKS1 gene (Y461C, 609883.0008; and R534Q, 609883.0009). The mutations were identified by high-throughput targeted exome sequencing of 144 known genes responsible for inherited retinal diseases. Functional studies of the variants were not performed.